Has Kathleen Marcum received payments from drug or device companies?

Yes. Drug and device makers reported $3,015 in general payments to Kathleen Marcum across 121 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kathleen Marcum did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kathleen Marcum come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kathleen Marcum

Physician Assistant · Lubbock, TXNPI 1154496974

Payments from drug & device makers

$3,015in general payments, 2019–2025

Across 121 payments — averaging $24.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Amgen$520
Otsuka America Pharmaceutical, Inc.$511
Bayer$509
Novo Nordisk$226
Boehringer Ingelheim$208
AstraZeneca$195
plus $846 from 15 others

What the payments were for

Food & beverage$3,015100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Amgen(2 entities)	12	$520
Otsuka America Pharmaceutical, Inc.	34	$511
Bayer	13	$509
Novo Nordisk	8	$226
Boehringer Ingelheim	11	$208
AstraZeneca(2 entities)	6	$195
Nuwellis, Inc.	2	$142
Lilly USA, LLC	6	$107
Calliditas Therapeutics US Inc.	4	$102
Takeda Pharmaceuticals U.S.A., Inc.	4	$100
AbbVie	5	$87
Dexcom, Inc.	3	$63
Arbor Pharmaceuticals, Inc.	3	$45
Vifor Pharma, Inc.	2	$41
Travere Therapeutics, Inc.	2	$40
Veloxis Pharmaceuticals, Inc.	1	$39
Outset Medical Inc	1	$21
Daiichi Sankyo Inc.	1	$17
Biohaven Pharmaceuticals, Inc.	1	$15
Fresenius USA Marketing, Inc.	1	$13
GSK	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,015 in reported general payments places this provider in the 80th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
OzempicSemaglutide	36	$45,462
FarxigaDapagliflozin Propanediol	26	$33,664
EliquisApixaban	26	$18,233
TrintellixVortioxetine Hydrobromide	23	$13,383
JardianceEmpagliflozin	13	$9,210
Fluticasone-SalmeterolFluticasone Propion/Salmeterol	12	$1,096
Levothyroxine Sodium	80	$770
Nifedipine ErNifedipine	32	$716
Pregabalin	35	$668
Esomeprazole Magnesium	19	$602
Gabapentin	39	$587
Nebivolol Hcl	12	$554
Albuterol Sulfate HfaAlbuterol Sulfate	15	$487
Rosuvastatin Calcium	34	$472
Celecoxib	22	$368

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Novo NordiskOzempic	$226	$45,46236 claims
AstraZenecaFarxiga	$195	$33,66426 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix	$100	$13,38323 claims
Boehringer IngelheimJardiance	$208	$9,21013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in Lubbock

Heidi JeffreysLubbock$259K
Cynthia TrickettDallas$1.3M
Kristine KuceraMelissa$797K
Selina SantosAustin$543K
Matthew BrunoMcKinney$538K
Anthony DerenciusSan Antonio$507K
Brooke HodnickSouthlake$479K
Holly GloverArlington$418K
Kirk GautierAthens$416K
Jaime RomanPlano$338K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →